Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
8015-91-6
Molecular formula
Not available
Molecular weight
Not available
Drug class
Botanical essential oilCinnamomum species volatile oil
Mechanism of action
Contains volatile constituents such as cinnamaldehyde and eugenol, with local antimicrobial and sensory effects in laboratory studies. The chemical profile depends on plant species, plant part and extraction method; no single therapeutic mechanism can be assigned to all cinnamon oils.
Indications / reported uses
Traditional flavouring and fragrance ingredient and, in selected products, topical or oral herbal preparation. No general FDA/EMA-approved medicinal indication can be assigned to cinnamon oil without a specific standardised product and label.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Cinnamon Oil PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Cinnamon Oil Permitted Daily Exposure (PDE) report (the Cinnamon Oil PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Cinnamon Oil Occupational Exposure Limit (OEL) report (the Cinnamon Oil OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.